Opioid use does not limit potent low-dose HIV-1 latency reversal agent boosting.
Lilie T, Bouzy J, Asundi A, Taylor J, Roche S, Olson A, Coxen K, Corry H, Jordan H, Clayton K, Lin N, Tsibris A.
Lilie T, et al. Among authors: taylor j.
medRxiv [Preprint]. 2023 Jun 3:2023.05.26.23290576. doi: 10.1101/2023.05.26.23290576.
medRxiv. 2023.
PMID: 37398278
Free PMC article.
Preprint.